Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Nov 14, 2011 · 10-Q · 45 days after period end · 0001193125-11-309615
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $350.35K | $364.57K |
| Net Income | -$1.81M | -$1.88M |
| EPS Diluted | -$0.32 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end
